查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1786996

Dupixent市場，規模，佔有率，趨勢，產業分析報告:各適應症，各流通管道，各地區-2025年～2034年市場預測

Dupixent Market Size, Share, Trends, Industry Analysis Report By Indication [Atopic Dermatitis (AD), Asthma, Chronic Rhinosinusitis with Nasal Polyps (CRSwNP)], By Distribution Channel, By Region - Market Forecast, 2025-2034
出版日期: | 出版商: Polaris Market Research | 英文 125 Pages | 商品交期: 最快1-2個工作天內

價格

根據 Polaris Market Research 的最新研究，預計到 2034 年，全球 Dupixent 市場規模將達到 287 億美元。本研究報告深入分析了當前的市場動態，並分析了未來的市場成長。

Dupixent 市場指的是 dupilumab（一種針對 2 型發炎相關特定蛋白質的生物藥物）的全球商業格局。該市場涵蓋 dupilumab 的各個環節，從研發到生產、分銷、銷售，最終到患者使用。 Dupixent 是一種處方藥，主要用於治療多種慢性發炎性疾病，包括中度至重度異位性皮膚炎、氣喘、伴隨鼻息肉的慢性鼻竇炎、嗜酸性食道炎、結節性癢疹以及一種慢性阻塞性肺病。該市場涵蓋整個價值鏈，包括製藥公司、醫療保健提供者以及受益於這種先進療法的患者。

Dupixent 市場正在經歷顯著的成長和演變，這得益於人們對 2 型發炎的理解日益加深，以及治療相關慢性疾病的巨大未滿足需求。 Dupixent 最初獲準用於治療異位性皮膚炎，此後已獲準用於多種適應症和年齡組，顯著擴展了其市場，並使其成為一種用途廣泛的治療選擇。 Dupixent 的作用機制是抑制白細胞介素 4 (IL-4) 和白細胞介素 13 (IL-13) 通路中的信號傳導，這使其有別於傳統療法，並提供了一種針對性的方法來解決這些複雜的疾病。這使得 Dupixent 獲得了處方醫生和患者的廣泛認可，鞏固了其在全球醫藥市場的地位。

Dupixent 市場報告重點

按適應症劃分，異位性皮膚炎 (AD) 將在 2024 年佔最大的市場佔有率。異位性皮膚炎發病率普遍較高，Dupixent 在治療中度至重度異位性皮膚炎方面已得到證實的療效，確保了其在市場上的領先地位和持續的需求。

依分銷管道劃分，2024年醫院藥局佔了Dupixent分銷的最大佔有率。這主要是因為Dupixent是一種特殊的生物製劑，通常需要在院內進行初始給藥和密切監測，這使得醫務人員能夠更好地管理其獨特的處理方式和病患教育需求。

依地區劃分，北美是Dupixent市場的領導者。這項優勢得益於其先進的醫療基礎設施、對創新生物製劑的高度認知和接受度、優惠的報銷政策以及大量的2型發炎疾病患者。亞太地區正迅速崛起，成為一個充滿活力、高成長的市場。這一增長受到多種因素的推動，包括醫療基礎設施的改善、可支配收入的增加以及人們對慢性發炎疾病先進治療方案的認識不斷提高。

賽諾菲和再生元是Dupixent市場的領導公司。

目錄

第1章 簡介

第2章 摘要整理

第3章 調查手法

第4章 Dupixent的全球市場的洞察

  • 市場概述
  • Dupixent市場動態
  • 開發平台分析
  • 市場集中度與特徵
    • 促進因素和機會
      • 2 型發炎性疾病盛行率不斷上升
      • 獲準適應症和年齡層的擴大
    • 限制因素和挑戰
      • 治療成本高
  • PESTEL分析
  • Dupixent市場趨勢
  • 價值鏈分析
  • COVID-19影響分析

第5章 全球Dupixent市場:各適應症

  • 主要調查結果
  • 簡介
  • 異位性皮膚炎(AD)
  • 氣喘
  • 伴隨鼻息肉的慢性鼻竇炎(CRSwNP)
  • 慢性阻塞性肺病（COPD）
  • 其他

第6章 全球Dupixent市場:各流通管道

  • 主要調查結果
  • 簡介
  • 醫院藥局
  • 零售藥局
  • 其他

第7章 全球Dupixent市場:各地區

  • 主要調查結果
  • 簡介
    • Dupixent市場評估:地區，2020年～2034年
  • 北美
    • 北美:各適應症，2020年～2034年
    • 北美:各流通管道，2020年～2034年
    • 美國
    • 加拿大
  • 歐洲
    • 歐洲:各適應症，2020年～2034年
    • 歐洲:各流通管道，2020年～2034年
    • 英國
    • 法國
    • 德國
    • 義大利
    • 西班牙
    • 荷蘭
    • 俄羅斯
    • 其他歐洲
  • 亞太地區
    • 亞太地區:各適應症，2020年～2034年
    • 亞太地區:各流通管道，2020年～2034年
    • 中國
    • 印度
    • 馬來西亞
    • 日本
    • 印尼
    • 韓國
    • 澳洲
    • 其他亞太地區
  • 中東·非洲
    • 中東·非洲:各適應症，2020年～2034年
    • 中東·非洲:各流通管道，2020年～2034年
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 南非
    • 其他中東·非洲
  • 南美
    • 南美:徵兆，2020年～2034年
    • 南美:各流通管道，2020年～2034年
    • 墨西哥
    • 巴西
    • 阿根廷
    • 其他南美國家

第8章 競爭情形

  • 擴大和收購的分析
    • 擴大
    • 收購
  • 聯盟/合作/協定/公開

第9章 企業簡介

  • Regeneron Pharmaceuticals
  • Sanofi
Product Code: PM5988

The global dupixent market size is expected to reach USD 28.70 billion by 2034, according to a new study by Polaris Market Research. The report "Dupixent Market Size, Share, Trends, Industry Analysis Report By Indication [Atopic Dermatitis (AD), Asthma, Chronic Rhinosinusitis with Nasal Polyps (CRSwNP)], By Distribution Channel, By Region - Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The Dupixent market refers to the global commercial landscape for dupilumab, a biologic medication that targets specific proteins involved in type 2 inflammation. This market includes all aspects from the research and development of dupilumab to its manufacturing, distribution, and sale, and ultimately its use by patients. Dupixent is a prescription-only medication primarily used to treat a range of chronic inflammatory conditions, including moderate-to-severe atopic dermatitis, asthma, chronic rhinosinusitis with nasal polyps, eosinophilic esophagitis, prurigo nodularis, and a specific type of chronic obstructive pulmonary disease. The market encompasses the entire value chain, involving pharmaceutical companies, healthcare providers, and the patients who benefit from this advanced therapy.

The Dupixent market has seen considerable growth and evolution, driven by the increasing understanding of type 2 inflammation and the significant unmet needs in treating associated chronic diseases. Initially approved for atopic dermatitis, Dupixent's market expansion has been greatly influenced by its subsequent regulatory approvals across various indications and age groups, making it a versatile treatment option. Its mechanism of action, which involves inhibiting the signaling of interleukin-4 (IL-4) and interleukin-13 (IL-13) pathways, differentiates it from traditional treatments and offers a targeted approach to managing these complex conditions. This has led to strong adoption among both prescribers and patients, contributing to its substantial presence in the global pharmaceutical landscape.

Dupixent Market Report Highlights

By indication, the atopic dermatitis (AD) segment held the largest share in 2024. Its widespread prevalence and Dupixent's established efficacy in treating moderate-to-severe forms of this chronic skin condition have ensured its leading position and continued demand within the market.

By distribution channel, the hospital pharmacies segment held the largest share in 2024 in Dupixent distribution. This is primarily because Dupixent, as a specialized biologic, often requires initial administration or close monitoring in a hospital setting, where healthcare professionals are equipped to manage its specific handling and patient education needs.

By region, North America is leading in the Dupixent market. This dominance is driven by its advanced healthcare infrastructure, high awareness and acceptance of innovative biologic therapies, favorable reimbursement policies, and a significant patient population suffering from type 2 inflammatory diseases. Asia Pacific is rapidly emerging as a dynamic and high-growth region for the market. This growth is propelled by several factors, including improving healthcare infrastructure, rising disposable incomes, and increasing awareness of advanced treatment options for chronic inflammatory diseases.

Key players in the market include Sanofi and Regeneron Pharmaceuticals.

Polaris Market Research has segmented the Dupixent market report based on indication, distribution channel, and region:

By Indication Outlook (Revenue - USD Billion, 2020-2034)

Atopic Dermatitis (AD)

Asthma

Chronic Rhinosinusitis with Nasal Polyps (CRSwNP)

Chronic Obstructive Pulmonary Disease (COPD)

Others

By Distribution Channel Outlook (Revenue - USD Billion, 2020-2034)

Hospital Pharmacies

Retail Pharmacies

Others

By Regional Outlook (Revenue - USD Billion, 2020-2034)

North America

U.S.

Canada

Europe

Germany

France

UK

Italy

Spain

Netherlands

Russia

Rest of Europe

Asia Pacific

China

Japan

India

Malaysia

South Korea

Indonesia

Australia

Vietnam

Rest of Asia Pacific

Middle East & Africa

Saudi Arabia

UAE

Israel

South Africa

Rest of Middle East & Africa

Latin America

Mexico

Brazil

Argentina

Rest of Latin America

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Dupixent Market Insights

  • 4.1. Dupixent Market - Market Snapshot
  • 4.2. Dupixent Market Dynamics
  • 4.3. Pipeline Analysis
  • 4.4. Market Concentration & Characteristics
    • 4.4.1. Drivers and Opportunities
      • 4.4.1.1. Rising Prevalence of Type 2 Inflammatory Diseases
      • 4.4.1.2. Broadening of Approved Indications and Age Groups
    • 4.4.2. Restraints and Challenges
      • 4.4.2.1. High treatment costs
  • 4.5. Porter's Five Forces Analysis
    • 4.5.1. Bargaining Power of Suppliers (Moderate)
    • 4.5.2. Threats of New Entrants: (Low)
    • 4.5.3. Bargaining Power of Buyers (Moderate)
    • 4.5.4. Threat of Substitute (Moderate)
    • 4.5.5. Rivalry among existing firms (High)
  • 4.6. PESTEL Analysis
  • 4.7. Dupixent Market Trends
  • 4.8. Value Chain Analysis
  • 4.9. COVID-19 Impact Analysis

5. Global Dupixent Market, by Indication

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Dupixent Market, by Indication, 2020-2034 (USD Billion)
  • 5.3. Atopic Dermatitis (AD)
    • 5.3.1. Global Dupixent Market, by Atopic Dermatitis (AD), by Region, 2020-2034 (USD Billion)
  • 5.4. Asthma
    • 5.4.1. Global Dupixent Market, by Asthma, by Region, 2020-2034 (USD Billion)
  • 5.5. Chronic Rhinosinusitis with Nasal Polyps (CRSwNP)
    • 5.5.1. Global Dupixent Market, by Chronic Rhinosinusitis with Nasal Polyps (CRSwNP), by Region, 2020-2034 (USD Billion)
  • 5.6. Chronic Obstructive Pulmonary Disease (COPD)
    • 5.6.1. Global Dupixent Market, by Chronic Obstructive Pulmonary Disease (COPD), by Region, 2020-2034 (USD Billion)
  • 5.7. Others
    • 5.7.1. Global Dupixent Market, by Others, by Region, 2020-2034 (USD Billion)

6. Global Dupixent Market, by Distribution Channel

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Dupixent Market, by Distribution Channel, 2020-2034 (USD Billion)
  • 6.3. Hospital Pharmacies
    • 6.3.1. Global Dupixent Market, by Hospital Pharmacies, by Region, 2020-2034 (USD Billion)
  • 6.4. Retail Pharmacies
    • 6.4.1. Global Dupixent Market, by Retail Pharmacies, by Region, 2020-2034 (USD Billion)
  • 6.5. Others
    • 6.5.1. Global Dupixent Market, by Others, by Region, 2020-2034 (USD Billion)

7. Global Dupixent Market, by Geography

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Dupixent Market Assessment, By Geography, 2020-2034 (USD Billion)
  • 7.3. Dupixent Market - North America
    • 7.3.1. North America: Dupixent Market, by Indication, 2020-2034 (USD Billion)
    • 7.3.2. North America: Dupixent Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 7.3.3. Dupixent Market - U.S.
      • 7.3.3.1. U.S.: Dupixent Market, by Indication, 2020-2034 (USD Billion)
      • 7.3.3.2. U.S.: Dupixent Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 7.3.4. Dupixent Market - Canada
      • 7.3.4.1. Canada: Dupixent Market, by Indication, 2020-2034 (USD Billion)
      • 7.3.4.2. Canada: Dupixent Market, by Distribution Channel, 2020-2034 (USD Billion)
  • 7.4. Dupixent Market - Europe
    • 7.4.1. Europe: Dupixent Market, by Indication, 2020-2034 (USD Billion)
    • 7.4.2. Europe: Dupixent Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 7.4.3. Dupixent Market - UK
      • 7.4.3.1. UK: Dupixent Market, by Indication, 2020-2034 (USD Billion)
      • 7.4.3.2. UK: Dupixent Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 7.4.4. Dupixent Market - France
      • 7.4.4.1. France: Dupixent Market, by Indication, 2020-2034 (USD Billion)
      • 7.4.4.2. France: Dupixent Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 7.4.5. Dupixent Market - Germany
      • 7.4.5.1. Germany: Dupixent Market, by Indication, 2020-2034 (USD Billion)
      • 7.4.5.2. Germany: Dupixent Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 7.4.6. Dupixent Market - Italy
      • 7.4.6.1. Italy: Dupixent Market, by Indication, 2020-2034 (USD Billion)
      • 7.4.6.2. Italy: Dupixent Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 7.4.7. Dupixent Market - Spain
      • 7.4.7.1. Spain: Dupixent Market, by Indication, 2020-2034 (USD Billion)
      • 7.4.7.2. Spain: Dupixent Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 7.4.8. Dupixent Market - Netherlands
      • 7.4.8.1. Netherlands: Dupixent Market, by Indication, 2020-2034 (USD Billion)
      • 7.4.8.2. Netherlands: Dupixent Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 7.4.9. Dupixent Market - Russia
      • 7.4.9.1. Russia: Dupixent Market, by Indication, 2020-2034 (USD Billion)
      • 7.4.9.2. Russia: Dupixent Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 7.4.10. Dupixent Market - Rest of Europe
      • 7.4.10.1. Rest of Europe: Dupixent Market, by Indication, 2020-2034 (USD Billion)
      • 7.4.10.2. Rest of Europe: Dupixent Market, by Distribution Channel, 2020-2034 (USD Billion)
  • 7.5. Dupixent Market - Asia Pacific
    • 7.5.1. Asia Pacific: Dupixent Market, by Indication, 2020-2034 (USD Billion)
    • 7.5.2. Asia Pacific: Dupixent Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 7.5.3. Dupixent Market - China
      • 7.5.3.1. China: Dupixent Market, by Indication, 2020-2034 (USD Billion)
      • 7.5.3.2. China: Dupixent Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 7.5.4. Dupixent Market - India
      • 7.5.4.1. India: Dupixent Market, by Indication, 2020-2034 (USD Billion)
      • 7.5.4.2. India: Dupixent Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 7.5.5. Dupixent Market - Malaysia
      • 7.5.5.1. Malaysia: Dupixent Market, by Indication, 2020-2034 (USD Billion)
      • 7.5.5.2. Malaysia: Dupixent Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 7.5.6. Dupixent Market - Japan
      • 7.5.6.1. Japan: Dupixent Market, by Indication, 2020-2034 (USD Billion)
      • 7.5.6.2. Japan: Dupixent Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 7.5.7. Dupixent Market - Indonesia
      • 7.5.7.1. Indonesia: Dupixent Market, by Indication, 2020-2034 (USD Billion)
      • 7.5.7.2. Indonesia: Dupixent Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 7.5.8. Dupixent Market - South Korea
      • 7.5.8.1. South Korea: Dupixent Market, by Indication, 2020-2034 (USD Billion)
      • 7.5.8.2. South Korea: Dupixent Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 7.5.9. Dupixent Market - Australia
      • 7.5.9.1. Australia: Dupixent Market, by Indication, 2020-2034 (USD Billion)
      • 7.5.9.2. Australia: Dupixent Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 7.5.10. Dupixent Market - Rest of Asia Pacific
      • 7.5.10.1. Rest of Asia Pacific: Dupixent Market, by Indication, 2020-2034 (USD Billion)
      • 7.5.10.2. Rest of Asia Pacific: Dupixent Market, by Distribution Channel, 2020-2034 (USD Billion)
  • 7.6. Dupixent Market - Middle East & Africa
    • 7.6.1. Middle East & Africa: Dupixent Market, by Indication, 2020-2034 (USD Billion)
    • 7.6.2. Middle East & Africa: Dupixent Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 7.6.3. Dupixent Market - Saudi Arabia
      • 7.6.3.1. Saudi Arabia: Dupixent Market, by Indication, 2020-2034 (USD Billion)
      • 7.6.3.2. Saudi Arabia: Dupixent Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 7.6.4. Dupixent Market - UAE
      • 7.6.4.1. UAE: Dupixent Market, by Indication, 2020-2034 (USD Billion)
      • 7.6.4.2. UAE: Dupixent Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 7.6.5. Dupixent Market - Israel
      • 7.6.5.1. Israel: Dupixent Market, by Indication, 2020-2034 (USD Billion)
      • 7.6.5.2. Israel: Dupixent Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 7.6.6. Dupixent Market - South Africa
      • 7.6.6.1. South Africa: Dupixent Market, by Indication, 2020-2034 (USD Billion)
      • 7.6.6.2. South Africa: Dupixent Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 7.6.7. Dupixent Market - Rest of Middle East & Africa
      • 7.6.7.1. Rest of Middle East & Africa: Dupixent Market, by Indication, 2020-2034 (USD Billion)
      • 7.6.7.2. Rest of Middle East & Africa: Dupixent Market, by Distribution Channel, 2020-2034 (USD Billion)
  • 7.7. Dupixent Market - Latin America
    • 7.7.1. Latin America: Dupixent Market, by Indication, 2020-2034 (USD Billion)
    • 7.7.2. Latin America: Dupixent Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 7.7.3. Dupixent Market - Mexico
      • 7.7.3.1. Mexico: Dupixent Market, by Indication, 2020-2034 (USD Billion)
      • 7.7.3.2. Mexico: Dupixent Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 7.7.4. Dupixent Market - Brazil
      • 7.7.4.1. Brazil: Dupixent Market, by Indication, 2020-2034 (USD Billion)
      • 7.7.4.2. Brazil: Dupixent Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 7.7.5. Dupixent Market - Argentina
      • 7.7.5.1. Argentina: Dupixent Market, by Indication, 2020-2034 (USD Billion)
      • 7.7.5.2. Argentina: Dupixent Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 7.7.6. Dupixent Market - Rest of Latin America
      • 7.7.6.1. Rest of Latin America: Dupixent Market, by Indication, 2020-2034 (USD Billion)
      • 7.7.6.2. Rest of Latin America: Dupixent Market, by Distribution Channel, 2020-2034 (USD Billion)

8. Competitive Landscape

  • 8.1. Expansion and Acquisition Analysis
    • 8.1.1. Expansion
    • 8.1.2. Acquisitions
  • 8.2. Partnerships/Collaborations/Agreements/Exhibitions

9. Company Profiles

  • 9.1. Regeneron Pharmaceuticals
    • 9.1.1. Company Overview
    • 9.1.2. Financial Performance
    • 9.1.3. Product Benchmarking
    • 9.1.4. Recent Development
  • 9.2. Sanofi
    • 9.2.1. Company Overview
    • 9.2.2. Financial Performance
    • 9.2.3. Product Benchmarking
    • 9.2.4. Recent Development

List of Tables:

  • Table 1 Global Dupixent Market, by Indication, 2020-2034 (USD Billion)
  • Table 2 Global Dupixent Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 3 North America: Dupixent Market, by Indication, 2020-2034 (USD Billion)
  • Table 4 North America: Dupixent Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 5 U.S.: Dupixent Market, by Indication, 2020-2034 (USD Billion)
  • Table 6 U.S.: Dupixent Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 7 Canada: Dupixent Market, by Indication, 2020-2034 (USD Billion)
  • Table 8 Canada: Dupixent Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 9 Europe: Dupixent Market, by Indication, 2020-2034 (USD Billion)
  • Table 10 Europe: Dupixent Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 11 UK: Dupixent Market, by Indication, 2020-2034 (USD Billion)
  • Table 12 UK: Dupixent Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 13 France: Dupixent Market, by Indication, 2020-2034 (USD Billion)
  • Table 14 France: Dupixent Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 15 Germany: Dupixent Market, by Indication, 2020-2034 (USD Billion)
  • Table 16 Germany: Dupixent Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 17 Italy: Dupixent Market, by Indication, 2020-2034 (USD Billion)
  • Table 18 Italy: Dupixent Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 19 Spain: Dupixent Market, by Indication, 2020-2034 (USD Billion)
  • Table 20 Spain: Dupixent Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 21 Netherlands: Dupixent Market, by Indication, 2020-2034 (USD Billion)
  • Table 22 Netherlands: Dupixent Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 23 Russia: Dupixent Market, by Indication, 2020-2034 (USD Billion)
  • Table 24 Russia: Dupixent Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 25 Rest of Europe: Dupixent Market, by Indication, 2020-2034 (USD Billion)
  • Table 26 Rest of Europe: Dupixent Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 27 Asia Pacific: Dupixent Market, by Indication, 2020-2034 (USD Billion)
  • Table 28 Asia Pacific: Dupixent Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 29 China: Dupixent Market, by Indication, 2020-2034 (USD Billion)
  • Table 30 China: Dupixent Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 31 India: Dupixent Market, by Indication, 2020-2034 (USD Billion)
  • Table 32 India: Dupixent Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 33 Malaysia: Dupixent Market, by Indication, 2020-2034 (USD Billion)
  • Table 34 Malaysia: Dupixent Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 35 Japan: Dupixent Market, by Indication, 2020-2034 (USD Billion)
  • Table 36 Japan: Dupixent Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 37 Indonesia: Dupixent Market, by Indication, 2020-2034 (USD Billion)
  • Table 38 Indonesia: Dupixent Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 39 South Korea: Dupixent Market, by Indication, 2020-2034 (USD Billion)
  • Table 40 South Korea: Dupixent Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 41 Australia: Dupixent Market, by Indication, 2020-2034 (USD Billion)
  • Table 42 Australia: Dupixent Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 43 Rest of Asia Pacific: Dupixent Market, by Indication, 2020-2034 (USD Billion)
  • Table 44 Rest of Asia Pacific: Dupixent Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 45 Middle East & Africa: Dupixent Market, by Indication, 2020-2034 (USD Billion)
  • Table 46 Middle East & Africa: Dupixent Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 47 Saudi Arabia: Dupixent Market, by Indication, 2020-2034 (USD Billion)
  • Table 48 Saudi Arabia: Dupixent Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 49 UAE: Dupixent Market, by Indication, 2020-2034 (USD Billion)
  • Table 50 UAE: Dupixent Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 51 Israel: Dupixent Market, by Indication, 2020-2034 (USD Billion)
  • Table 52 Israel: Dupixent Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 53 South Africa: Dupixent Market, by Indication, 2020-2034 (USD Billion)
  • Table 54 South Africa: Dupixent Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 55 Rest of Middle East & Africa: Dupixent Market, by Indication, 2020-2034 (USD Billion)
  • Table 56 Rest of Middle East & Africa: Dupixent Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 57 Latin America: Dupixent Market, by Indication, 2020-2034 (USD Billion)
  • Table 58 Latin America: Dupixent Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 59 Mexico: Dupixent Market, by Indication, 2020-2034 (USD Billion)
  • Table 60 Mexico: Dupixent Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 61 Brazil: Dupixent Market, by Indication, 2020-2034 (USD Billion)
  • Table 62 Brazil: Dupixent Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 63 Argentina: Dupixent Market, by Indication, 2020-2034 (USD Billion)
  • Table 64 Argentina: Dupixent Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 65 Rest of Latin America: Dupixent Market, by Indication, 2020-2034 (USD Billion)
  • Table 66 Rest of Latin America: Dupixent Market, by Distribution Channel, 2020-2034 (USD Billion)

List of Figures:

  • Figure 1. Global Dupixent Market, 2020-2034 (USD Billion)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top-Down & Bottom-Up Price
  • Figure 4. Market by Geography
  • Figure 5. Porter's Five Forces
  • Figure 6. Market by Indication
  • Figure 7. Global Dupixent Market, by Indication, 2024 & 2034 (USD Billion)
  • Figure 8. Market by Distribution Channel
  • Figure 9. Global Dupixent Market, by Distribution Channel, 2024 & 2034 (USD Billion)